Show Notes
N4 Pharma is a specialist pharmaceutical company developing a novel delivery system for cancer and vaccine treatments using its unique silica nanoparticle delivery system called Nuvec®.
We spoke with Nigel today and asked about the progress the company is making and shareholders question.
N4 Pharma's business model is to partner with companies developing novel antigens for cancer and vaccine treatments to use Nuvec® as the delivery vehicle to get their antigen into cells to express the protein needed for the required immunity. As these products progress through pre-clinical and clinical programs, N4 Pharma will seek to receive upfront payments, milestone payments and ultimately royalty payments once products reach the market.
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
https://www.share-talk.com/nigel-theobald-ceo-of-n4-pharma-plc-n4p-l-interview/
Listen On
Also Listen
-
Zak Mir talks to Dr Kerim Sener, Managing Director, Ariana Resources
Zak Mir speaks with Dr Kerim Sener, Managing Director of Ariana Resources (AIM: -
Zak Mir talks to Ajax Resources CEO Ippolito Cattaneo
Zak Mir talks to Ippolito Cattaneo, CEO of Ajax Resources, as the natural resour -
Gelion’s John Wood discusses latest developments with Zak Mir
Zak Mir speaks with John Wood, CEO of Gelion (AIM: GELN), following the release -
Zak Mir spoke with Australian Gold and Copper Ltd (ASX:AGC) MD Glen Diemar on today’s Achilles results
Achilles Northern Zone Delivers Exceptional Grades AGC Managing Director, Glen